Are Shares Of The Hain Celestial Group, Inc. (HAIN) Really Worth?

The Hain Celestial Group, Inc. (HAIN) has seen some recent movement in the stock market and its stock were last quoted at $34.90 yesterday. People are starting to take notice of HAIN as the stock traded as high as $35.16 and as low as $34.44 in the last market day.

The Hain Celestial Group, Inc. (HAIN) average trading volume is 664.40K. However, in the last market day The Hain Celestial Group, Inc. (HAIN) traded 666,137 shares. The First downside support level on HAIN is $34.39 and the First resistance level on HAIN is $36.79. HAIN fifty day moving average is $34.66 and HAIN 200 day moving average is $31.89.

The Hain Celestial Group, Inc. (HAIN) most current performance has been indicated by the recent movement in HAIN stock. HAIN has performed 5.22% over the past month, HAIN has performed 3.10% over the past 3 months and HAIN has shown 53.20% over the past 1 year. The Hain Celestial Group, Inc. (HAIN) has a 52 week range of $18.12 to $36.90. The Hain Celestial Group, Inc. (HAIN) is trading 92.60% from its 52 week low and -5.42% from its 52 week high. The Hain Celestial Group, Inc. (HAIN) is indicating a 8.61% short float indicating the quantity short in the float.

HAIN has 101.90M shares outstanding and 99.97M shares in the float. The Hain Celestial Group, Inc. (HAIN) at this time has a market cap of $3.52B and income of 25.60M. The EPS next quarter for HAIN is 0.20 and projected EPS next year is 17.29%. The market cap of The Hain Celestial Group, Inc. (HAIN) at $3.52B signifies how many People own shares of HAIN and is calculated off the last price ($34.90) of HAIN and the quantity of shares outstanding (101.90M) with The Hain Celestial Group, Inc. (HAIN).

The Hain Celestial Group, Inc. (HAIN) has total cash (mrq) of 37.77M, total cash per share (mrq) of 0.37, total debt of HAIN rests at 378.93M and total debt/equity (mrq) is 26.25. . The Hain Celestial Group, Inc. (HAIN) operational cash flow (ttm) is 151.17M, HAIN leveraged free cash flow (ttm) is 146.18M.

HAIN is trading -1.46% below (bearish) its SMA20, 1.97% above (bullish) its SMA50 and 17.45% above (bullish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...